NEUROSENSE THERAPEUTICS LTD's ticker is and the CUSIP is M74240108. A total of 7 filers reported holding NEUROSENSE THERAPEUTICS LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $149,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,266,000 | $1,886,340 | 0.03% |
| MEITAV INVESTMENT HOUSE LTD | 190,000 | $283,100 | 0.00% |
| Vanguard Personalized Indexing Management, LLC | 11,192 | $16,676 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CWM, LLC | 1,000 | $1 | 0.00% |
| JPMORGAN CHASE & CO | 1,304 | $1,904 | 0.00% |
| Point72 Asset Management, L.P. | 100,000 | $149,000 | 0.00% |